202 related articles for article (PubMed ID: 2690557)
1. Prognosis in high-grade soft tissue sarcomas. The Scandinavian Sarcoma Group experience in a randomized adjuvant chemotherapy trial.
Alvegård TA; Berg NO; Ranstam J; Rydholm A; Rööser B
Acta Orthop Scand; 1989 Oct; 60(5):517-21. PubMed ID: 2690557
[TBL] [Abstract][Full Text] [Related]
2. Cellular DNA content and prognosis of high-grade soft tissue sarcoma: the Scandinavian Sarcoma Group experience.
Alvegard TA; Berg NO; Baldetorp B; Fernö M; Killander D; Ranstam J; Rydholm A; Akerman M
J Clin Oncol; 1990 Mar; 8(3):538-47. PubMed ID: 2407813
[TBL] [Abstract][Full Text] [Related]
3. Adjuvant chemotherapy with doxorubicin in high-grade soft tissue sarcoma: a randomized trial of the Scandinavian Sarcoma Group.
Alvegård TA; Sigurdsson H; Mouridsen H; Solheim O; Unsgaard B; Ringborg U; Dahl O; Nordentoft AM; Blomqvist C; Rydholm A
J Clin Oncol; 1989 Oct; 7(10):1504-13. PubMed ID: 2674336
[TBL] [Abstract][Full Text] [Related]
4. Adjuvant chemotherapy and postoperative radiotherapy in high-risk soft tissue sarcoma patients defined by biological risk factors-A Scandinavian Sarcoma Group study (SSG XX).
Sundby Hall K; Bruland ØS; Bjerkehagen B; Zaikova O; Engellau J; Hagberg O; Hansson L; Hagberg H; Ahlström M; Knobel H; Papworth K; Zemmler M; Goplen D; Bauer HCF; Eriksson M
Eur J Cancer; 2018 Aug; 99():78-85. PubMed ID: 29929092
[TBL] [Abstract][Full Text] [Related]
5. Prognostic factors predictive of survival and local recurrence for extremity soft tissue sarcoma.
Singer S; Corson JM; Gonin R; Labow B; Eberlein TJ
Ann Surg; 1994 Feb; 219(2):165-73. PubMed ID: 8129487
[TBL] [Abstract][Full Text] [Related]
6. Adjuvant chemotherapy for soft tissue sarcomas.
Mertens WC; Bramwell VH
Hematol Oncol Clin North Am; 1995 Aug; 9(4):801-15. PubMed ID: 7490242
[TBL] [Abstract][Full Text] [Related]
7. A prospective randomized trial of adjuvant chemotherapy with bolus versus continuous infusion of doxorubicin in patients with high-grade extremity soft tissue sarcoma and an analysis of prognostic factors.
Casper ES; Gaynor JJ; Hajdu SI; Magill GB; Tan C; Friedrich C; Brennan MF
Cancer; 1991 Sep; 68(6):1221-9. PubMed ID: 1873773
[TBL] [Abstract][Full Text] [Related]
8. Systemic adjuvant chemotherapy for soft tissue sarcomas.
Zalupski MM; Baker LH
Hematol Oncol Clin North Am; 1995 Aug; 9(4):787-800. PubMed ID: 7490241
[TBL] [Abstract][Full Text] [Related]
9. The management of adult soft tissue sarcomas.
Mendenhall WM; Indelicato DJ; Scarborough MT; Zlotecki RA; Gibbs CP; Mendenhall NP; Mendenhall CM; Enneking WF
Am J Clin Oncol; 2009 Aug; 32(4):436-42. PubMed ID: 19657238
[TBL] [Abstract][Full Text] [Related]
10. Adjuvant CYVADIC chemotherapy for adult soft tissue sarcoma--reduced local recurrence but no improvement in survival: a study of the European Organization for Research and Treatment of Cancer Soft Tissue and Bone Sarcoma Group.
Bramwell V; Rouesse J; Steward W; Santoro A; Schraffordt-Koops H; Buesa J; Ruka W; Priario J; Wagener T; Burgers M
J Clin Oncol; 1994 Jun; 12(6):1137-49. PubMed ID: 8201375
[TBL] [Abstract][Full Text] [Related]
11. The influence of local recurrence of extremity soft tissue sarcoma on metastasis and survival.
Stotter AT; A'Hern RP; Fisher C; Mott AF; Fallowfield ME; Westbury G
Cancer; 1990 Mar; 65(5):1119-29. PubMed ID: 2302663
[TBL] [Abstract][Full Text] [Related]
12. Extremity soft tissue sarcomas: analysis of prognostic variables in 300 cases and evaluation of tumor necrosis as a factor in stratifying higher-grade sarcomas.
Lack EE; Steinberg SM; White DE; Kinsella T; Glatstein E; Chang AE; Rosenberg SA
J Surg Oncol; 1989 Aug; 41(4):263-73. PubMed ID: 2755144
[TBL] [Abstract][Full Text] [Related]
13. Five-year results from a Scandinavian sarcoma group study (SSG XIII) of adjuvant chemotherapy combined with accelerated radiotherapy in high-risk soft tissue sarcoma of extremities and trunk wall.
Jebsen NL; Bruland ØS; Eriksson M; Engellau J; Turesson I; Folin A; Trovik CS; Hall KS
Int J Radiat Oncol Biol Phys; 2011 Dec; 81(5):1359-66. PubMed ID: 20933339
[TBL] [Abstract][Full Text] [Related]
14. Survival in soft tissue sarcoma. Prognostic variables identified by multivariate analysis.
Rööser B; Attewell R; Berg NO; Rydholm A
Acta Orthop Scand; 1987 Oct; 58(5):516-22. PubMed ID: 3425281
[TBL] [Abstract][Full Text] [Related]
15. Value of peri-operative chemotherapy in patients with CINSARC high-risk localized grade 1 or 2 soft tissue sarcoma: study protocol of the target selection phase III CHIC-STS trial.
Filleron T; Le Guellec S; Chevreau C; Cabarrou B; Lesluyes T; Lodin S; Massoubre A; Mounier M; Poublanc M; Chibon F; Valentin T
BMC Cancer; 2020 Jul; 20(1):716. PubMed ID: 32736540
[TBL] [Abstract][Full Text] [Related]
16. Prognostic factors affecting survival in metastatic soft tissue sarcoma: an analysis of 110 patients.
Iqbal N; Shukla NK; Deo SV; Agarwala S; Sharma DN; Sharma MC; Bakhshi S
Clin Transl Oncol; 2016 Mar; 18(3):310-6. PubMed ID: 26243399
[TBL] [Abstract][Full Text] [Related]
17. Prognosis in soft tissue sarcoma.
Rööser B
Acta Orthop Scand Suppl; 1987; 225():1-54. PubMed ID: 3480678
[TBL] [Abstract][Full Text] [Related]
18. Doxorubicin alone versus intensified doxorubicin plus ifosfamide for first-line treatment of advanced or metastatic soft-tissue sarcoma: a randomised controlled phase 3 trial.
Judson I; Verweij J; Gelderblom H; Hartmann JT; Schöffski P; Blay JY; Kerst JM; Sufliarsky J; Whelan J; Hohenberger P; Krarup-Hansen A; Alcindor T; Marreaud S; Litière S; Hermans C; Fisher C; Hogendoorn PC; dei Tos AP; van der Graaf WT;
Lancet Oncol; 2014 Apr; 15(4):415-23. PubMed ID: 24618336
[TBL] [Abstract][Full Text] [Related]
19. Forearm soft tissue sarcoma: tumors characteristics and oncologic outcomes following limb salvage surgery.
Baroudi MR; Ferguson PC; Wunder JS; Isler MH; Mottard S; Werier JA; Turcotte RE
J Surg Oncol; 2014 Nov; 110(6):676-81. PubMed ID: 24910319
[TBL] [Abstract][Full Text] [Related]
20. A staging system for soft-tissue sarcoma and its evaluation in relation to treatment.
Tomita Y; Kuratsu S; Naka N; Uchida A; Ono K; Ohsawa M; Aozasa K
Int J Cancer; 1994 Jul; 58(2):168-73. PubMed ID: 8026876
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
